Reuters logo
BRIEF-Sun Pharma & ICGEB enter pact to develop novel dengue vaccine for India, global markets
October 19, 2016 / 6:40 AM / a year ago

BRIEF-Sun Pharma & ICGEB enter pact to develop novel dengue vaccine for India, global markets

Oct 19 (Reuters) - Sun Pharmaceutical Industries Ltd :

* Sun Pharma & ICGEB announce new exclusive collaboration to develop novel dengue vaccine for India & global markets

* Says current collaboration is focussed on developing a novel, safe & effective vaccine for the prevention of dengue

* Sun pharma to explore global commercialisation opportunities for vaccine across India, emerging markets, western Europe, Japan, USA

* Sun Pharma to set-up dengue vaccine advisory group to provide technical,regulatory support to vaccine development program

* Co to be exclusively responsible for all regulatory filings for product globally including CDSCO-India, WHO, USFDA, EMA, MHRA, etc Source text: bit.ly/2e0noLf Further company coverage: (Bengaluru newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below